Original Research
Copyright ©The Author(s) 1997. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 1997; 3(3): 160-162
Published online Sep 15, 1997. doi: 10.3748/wjg.v3.i3.160
Preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers
Guo-Jun Wu, Xiang-Nian Shan, Ming-Fa Li, Shao-Lin Shi, Qi-Ping Zheng, Long Yu, Shou-Yuan Zhao
Guo-Jun Wu, Shao-Lin Shi, Qi-Ping Zheng, Long Yu, Shou-Yuan Zhao, Institute of Genetics, Fudan University, Shanghai 200433, China
Xiang-Nian Shan, Ming-Fa Li, Biological Department of Nanjing Railway Medical College, Nanjing 210009, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China (No. 39480018), Natural Science Foundation of Jiangsu Province, No. BK93154315, and Outstanding Youth Teachers Foundation of Jiangsu Province, No. QZ91014.
Correspondence to: Dr. Guo-Jun Wu, Institute of Genetics, Fudan University, Shanghai 200433, China
Telephone: +86-21-65492222-4107
Received: November 2, 1996
Revised: January 25, 1997
Accepted: February 22, 1997
Published online: September 15, 1997
Abstract

AIM: To evaluate the role of p53 in the development and progression of colorectal cancer and gastric carcinoma by analyzing the loss of heterozygosity (LOH) at 17p13.1 and 17p13.3.

METHODS: LOH at the p53 gene locus and 17p13.3 were examined in 22 cases of gastric carcinoma and 14 cases of colorectal cancer by Southern blot analysis.

RESULTS: Of the 22 gastrocarcinoma cases, 12 (54%) were heterozygous and LOH was detected in 6 (50%) of the 12 informative cases. In the 14 colorectal cancer cases, 10 (71%) were heterozygous, and LOH was detected in 6 (60%) of the 10 informative cases.

CONCLUSION: LOH at the p53 gene locus is a frequent event in multiple step carcinogenesis progression. The high frequency of LOH at 17p13.3 suggests that there may be another tumor suppresser gene in that chromosome region.

Keywords: Stomach neoplasms; Colorectal neoplasms; p53 gene; Heterozygosity loss; Genes, suppressor, tumor